Revisions were made on March 7, 2020, to reflect the following:
- Characteristics of patients with confirmed COVID-19 based on recent epidemiologic data from China, including characteristics of patients with COVID-19 admitted to the intensive care unit and data on pediatric cases
- Data regarding SARS-CoV-2 viral shedding among asymptomatic persons, and data from a recent report of viable SARS-CoV-2 isolation from stool
- Accessibility of investigational drug therapies for COVID-19 treatment through clinical trial enrollment in the United States
- Recently published pediatric surviving sepsis guidance
Updated March 7, 2020
This interim guidance is for clinicians caring for patients with confirmed infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease (COVID-19).
Find the full note HERE!